Robust Dual Enzyme Cascade‐Catalytic Cholesterol Depletion for Reverse Tumor Multidrug Resistance

Jialing Guo,Xiaoming Du,Jingshu Huang,Chenxin Liu,Yingying Zhou,Ying Li,Bin Du

DOI: https://doi.org/10.1002/adhm.202200859

IF: 10

2022-08-04

Advanced Healthcare Materials

Abstract:Although combination drugs and p‐glycoprotein inhibitors are the main methods to solve multidrug resistance, these methods ignore the pathological structure of drug‐resistant cells and extremely limit curative effect. Herein, a new paradigm of reversing multidrug resistance with abnormal expression of cholesterol as the target was proposed, which used the cascade catalysis of "natural enzyme" cholesterol oxidase (COD) and "nano enzyme" ZrMOF(Cu) to convert cholesterol into the highly cytotoxic hydroxyl radicals. The DOX loaded nanoparticles (DOX@COD‐MOF) can significantly reduce the cholesterol content of cancer cells via COD, which decrease the rigidity of drug resistant cancer cell membranes and restore the sensitivity of multidrug‐resistant cells to DOX. Afterward, DOX@COD‐MOF was encapsulated by cancer cell membranes (CCM) to construct a bionic "dual enzyme catalytic cascade nano‐reactor" (DOX@COD‐MOF@CCM). Such a rational design presents a preferential accumulation tendency to tumor sites due to the homologous targeting mechanism of CCM, and affords 94.4% in tumor growth suppression without systemic toxicity in vivo. This work aims to achieve the therapeutic purpose of high efficiency and low toxicity. It has the characteristics of "converting enemy into friend", and opens up a promising way for effectively reversing multidrug resistance of tumors. This article is protected by copyright. All rights reserved

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials